{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:26:30Z","timestamp":1794864390762,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422744262\u2013TRR 289"],"award-info":[{"award-number":["422744262\u2013TRR 289"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract\n<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Systemic inflammation triggers a wide range of sickness symptoms, including bodily discomfort and affective symptoms, which are relevant to numerous health conditions. While extensive research in the placebo field demonstrates that positive expectations can improve symptoms, it remains unclear if interventions designed to augment positive treatment expectations can alleviate sickness symptoms in the context of immunomodulatory drug therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this randomized, controlled, fully balanced 2\u2009\u00d7\u20092 factorial placebo design, <jats:italic>N<\/jats:italic>\u2009=\u2009124 healthy volunteers received either active ibuprofen treatment (600\u00a0mg per os) or placebo, combined with either a positive or neutral labeling of the treatment by the physician. All participants were intravenously injected with lipopolysaccharide (LPS, 0.8\u00a0ng per kg of body weight) as a translational model of inflammation-induced sickness symptoms. Primary outcomes were bodily and affective symptoms, assessed at baseline and up to 6\u00a0h after injection, along with a range of inflammatory markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ibuprofen substantially alleviated inflammation-induced symptoms. Positive labeling also improved bodily and affective symptoms of sickness, even in placebo-treated groups. Notably, positive labeling enhanced ibuprofen\u2019s efficacy for alleviating affective symptoms, supporting that expectations can boost the efficacy of a highly effective anti-inflammatory treatment. However, labeling did not influence changes in physiological markers of inflammation, suggesting that the effects of expectations primarily act through mechanisms distinct from direct modulation of peripheral immune responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Placebo mechanisms engaged by physician communication can independently alleviate inflammation-induced symptom burden and enhance the efficacy of an anti-inflammatory medication. Results underscore the critical role of healthcare provider communication and pave the way for improved treatment strategies for conditions characterized by inflammation-driven symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>DRKS00023088, registration website German Clinical Trials Register (date registered: 10\/22\/2020).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-04292-8","type":"journal-article","created":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:02:10Z","timestamp":1754262130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Placebo effects improve sickness symptoms and drug efficacy during systemic inflammation: a randomized controlled trial in human experimental endotoxemia"],"prefix":"10.1186","volume":"23","author":[{"given":"Justine","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Reinold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schedlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Elsenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"4292_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43955","volume":"5","author":"JW Haas","year":"2022","unstructured":"Haas JW, Bender FL, Ballou S, Kelley JM, Wilhelm M, Miller FG, et al. Frequency of adverse events in the placebo arms of COVID-19 vaccine trials: a systematic review and meta-analysis. JAMA Netw Open. 2022;5: e2143955.","journal-title":"JAMA Netw Open"},{"key":"4292_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.irn.2018.01.001","volume":"138","author":"M Hadamitzky","year":"2018","unstructured":"Hadamitzky M, Sondermann W, Benson S, Schedlowski M. Placebo effects in the immune system. Int Rev Neurobiol. 2018;138:39\u201359.","journal-title":"Int Rev Neurobiol"},{"key":"4292_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41584-018-0110-9","volume":"14","author":"E Kravvariti","year":"2018","unstructured":"Kravvariti E, Kitas GD, Mitsikostas DD, Sfikakis PP. Nocebos in rheumatology: emerging concepts and their implications for clinical practice. Nat Rev Rheumatol. 2018;14:727\u201340.","journal-title":"Nat Rev Rheumatol"},{"key":"4292_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3923","volume":"12","author":"P Enck","year":"2013","unstructured":"Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12:191\u2013204.","journal-title":"Nat Rev Drug Discov"},{"key":"4292_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrn3976","volume":"16","author":"TD Wager","year":"2015","unstructured":"Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16:403\u201318.","journal-title":"Nat Rev Neurosci"},{"key":"4292_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(18)32356-0","volume":"392","author":"E Bullmore","year":"2018","unstructured":"Bullmore E. The art of medicine: Inflamed depression. Lancet. 2018;392:1189\u201390.","journal-title":"Lancet"},{"key":"4292_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3621","volume":"14","author":"PM Grace","year":"2014","unstructured":"Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14:217\u201331.","journal-title":"Nat Rev Immunol"},{"key":"4292_CR8","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41380-020-00869-2","volume":"26","author":"J Lasselin","year":"2021","unstructured":"Lasselin J, Lekander M, Benson S, Schedlowski M, Engler H. Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression. Mol Psychiatry. 2021;26:3672\u201383.","journal-title":"Mol Psychiatry"},{"key":"4292_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000534467","volume":"30","author":"S Benson","year":"2023","unstructured":"Benson S, Karshikoff B. How can experimental endotoxemia contribute to our understanding of pain? A narrative review. Neuroimmunomodulation. 2023;30:250\u201367.","journal-title":"Neuroimmunomodulation"},{"key":"4292_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1056\/NEJMra1907805","volume":"382","author":"L Colloca","year":"2020","unstructured":"Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382:554\u201361.","journal-title":"N Engl J Med"},{"key":"4292_CR11","doi-asserted-by":"publisher","first-page":"70ra14","DOI":"10.1126\/scitranslmed.3001244","volume":"3","author":"U Bingel","year":"2011","unstructured":"Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3:70ra14.","journal-title":"Sci Transl Med"},{"key":"4292_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02638-0","volume":"20","author":"J Stuhlreyer","year":"2022","unstructured":"Stuhlreyer J, Roder C, Krug F, Zollner C, Flor H, Klinger R. A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial. BMC Med. 2022;20: 469.","journal-title":"BMC Med"},{"key":"4292_CR13","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/j.pain.0000000000001546","volume":"160","author":"S Benson","year":"2019","unstructured":"Benson S, Hagen S, Hoffmann O, Pasler A, Bingel U, Schedlowski M, et al. Can a brief psychological expectancy intervention improve postoperative pain? A randomized, controlled trial in patients with breast cancer. Pain. 2019;160:1562\u201371.","journal-title":"Pain"},{"key":"4292_CR14","doi-asserted-by":"publisher","first-page":"218ra215","DOI":"10.1126\/scitranslmed.3006175","volume":"6","author":"S Kam-Hansen","year":"2014","unstructured":"Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014;6:218ra215.","journal-title":"Sci Transl Med"},{"key":"4292_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.09.015","volume":"35","author":"M Schedlowski","year":"2014","unstructured":"Schedlowski M, Engler H, Grigoleit JS. Endotoxin-induced experimental systemic inflammation in humans: a model to disentangle immune-to-brain communication. Brain Behav Immun. 2014;35:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"4292_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2023.06.005","volume":"112","author":"S Benson","year":"2023","unstructured":"Benson S, Labrenz F, Kotulla S, Brotte L, R\u00f6dder P, Tebbe B, et al. Amplified gut feelings under inflammation and depressed mood: a randomized fMRI trial on interoceptive pain in healthy volunteers. Brain Behav Immun. 2023;112:132\u20137.","journal-title":"Brain Behav Immun"},{"key":"4292_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bbi.2018.09.008","volume":"74","author":"J Lasselin","year":"2018","unstructured":"Lasselin J, Petrovic P, Olsson MJ, Paues G\u00f6ranson S, Lekander M, Jensen KB, et al. Sickness behavior is not all about the immune response: possible roles of expectations and prediction errors in the worry of being sick. Brain Behav Immun. 2018;74:213\u201321.","journal-title":"Brain Behav Immun"},{"key":"4292_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10067-015-3009-8","volume":"35","author":"H van Middendorp","year":"2016","unstructured":"van Middendorp H, Kox M, Pickkers P, Evers AW. The role of outcome expectancies for a training program consisting of meditation, breathing exercises, and cold exposure on the response to endotoxin administration: a proof-of-principle study. Clin Rheumatol. 2016;35:1081\u20135.","journal-title":"Clin Rheumatol"},{"key":"4292_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cpt.618","volume":"102","author":"S Benson","year":"2017","unstructured":"Benson S, Engler H, La A, Rebernik L, Spreitzer I, Schedlowski M, et al. What makes you feel sick after inflammation? Predictors of acute and persisting physical sickness symptoms induced by experimental endotoxemia. Clin Pharmacol Ther. 2017;102:141\u201351.","journal-title":"Clin Pharmacol Ther"},{"key":"4292_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbi.2014.05.001","volume":"41","author":"A Wegner","year":"2014","unstructured":"Wegner A, Elsenbruch S, Maluck J, Grigoleit JS, Engler H, J\u00e4ger M, et al. Inflammation-induced hyperalgesia: effects of timing, dosage, and negative affect on somatic pain sensitivity in human experimental endotoxemia. Brain Behav Immun. 2014;41:46\u201354.","journal-title":"Brain Behav Immun"},{"key":"4292_CR21","doi-asserted-by":"publisher","first-page":"9088","DOI":"10.1038\/s41598-025-93589-y","volume":"15","author":"A Mostauli","year":"2025","unstructured":"Mostauli A, Rauh J, Gamer M, B\u00fcchel C, Rief W, Brassen S. Placebo treatment entails resource-dependent downregulation of negative inputs. Sci Rep. 2025;15:9088. https:\/\/doi.org\/10.1038\/s41598-025-93589-y.","journal-title":"Sci Rep"},{"key":"4292_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbi.2020.06.022","volume":"88","author":"S Benson","year":"2020","unstructured":"Benson S, Engler H, Wegner A, Schedlowski M, Elsenbruch S. Elucidating vulnerability to inflammation-induced hyperalgesia: predictors of increased musculoskeletal pain sensitivity during experimental endotoxemia. Brain Behav Immun. 2020;88:302\u20137. https:\/\/doi.org\/10.1016\/j.bbi.2020.06.022.","journal-title":"Brain Behav Immun"},{"key":"4292_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2023.152431","volume":"127","author":"LA Basedow","year":"2023","unstructured":"Basedow LA, Fischer A, Benson S, Bingel U, Brassen S, B\u00fcchel C, Engler H, Mueller EM, Schedlowski M, Rief W. The influence of psychological traits and prior experience on treatment expectations. Compr Psychiatry. 2023;127: 152431. https:\/\/doi.org\/10.1016\/j.comppsych.2023.152431.","journal-title":"Compr Psychiatry"},{"key":"4292_CR24","volume-title":"The state-trait anxiety depression inventory (STADI)","author":"L Laux","year":"2013","unstructured":"Laux L, Hock M, Bergner-K\u00f6ther R, Hodapp V, Renner KH, Merzbacher G. The state-trait anxiety depression inventory (STADI). Goettingen: Hogrefe; 2013."},{"key":"4292_CR25","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/mp.2016.264","volume":"22","author":"H Engler","year":"2017","unstructured":"Engler H, Brendt P, Wischermann J, Wegner A, R\u00f6hling R, Schoemberg T, et al. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms. Mol Psychiatry. 2017;22:1448\u201354.","journal-title":"Mol Psychiatry"},{"key":"4292_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbi.2014.11.014","volume":"46","author":"B Karshikoff","year":"2015","unstructured":"Karshikoff B, Lekander M, Soop A, Lindstedt F, Ingvar M, Kosek E, et al. Modality and sex differences in pain sensitivity during human endotoxemia. Brain Behav Immun. 2015;46:35\u201343.","journal-title":"Brain Behav Immun"},{"key":"4292_CR27","doi-asserted-by":"publisher","unstructured":"Englert R, Schedlowski M, Engler H, Rief W, B\u00fcchel, C, Bingel U, Spisak T. ALIIAS: Anonymization with LimeSurvey Integration and II-Factor Authentication for Scientific Research. https:\/\/doi.org\/10.2139\/ssrn.4089108. Available at SSRN: https:\/\/ssrn.com\/abstract=4089108.","DOI":"10.2139\/ssrn.4089108"},{"key":"4292_CR28","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI9523","volume":"105","author":"BF Mcadam","year":"2000","unstructured":"Mcadam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest. 2000;105:1473\u201382.","journal-title":"J Clin Invest"},{"key":"4292_CR29","volume-title":"Manual for the state-trait anxiety inventory","author":"CD Spielberger","year":"1970","unstructured":"Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychology Press; 1970."},{"key":"4292_CR30","volume-title":"Multi dimensional mood questionnaire (MDBF)","author":"R Steyer","year":"1997","unstructured":"Steyer R, Schwenkmezger P, Notz P, Eid M. Multi dimensional mood questionnaire (MDBF). Goettingen: Hogrefe; 1997."},{"key":"4292_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/00207459008994241","volume":"52","author":"T Akerstedt","year":"1990","unstructured":"Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990;52:29\u201337.","journal-title":"Int J Neurosci"},{"key":"4292_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbi.2019.10.020","volume":"83","author":"J Lasselin","year":"2020","unstructured":"Lasselin J, Karshikoff B, Axelsson J, \u00c5kerstedt T, Benson S, Engler H, Schedlowski M, Jones M, Lekander M, Andreasson A. Fatigue and sleepiness responses to experimental inflammation and exploratory analysis of the effect of baseline inflammation in healthy humans. Brain Behav Immun. 2020;83:309\u201314.","journal-title":"Brain Behav Immun"},{"key":"4292_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","volume":"21","author":"WC Drevets","year":"2022","unstructured":"Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov. 2022;21:224\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"4292_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","volume":"118","author":"W Rief","year":"2009","unstructured":"Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord. 2009;118:1\u20138.","journal-title":"J Affect Disord"},{"key":"4292_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2999","volume":"9","author":"M Zunhammer","year":"2017","unstructured":"Zunhammer M, Ploner M, Engelbrecht C, Bock J, Kessner SS, Bingel U. The effects of treatment failure generalize across different routes of drug administration. Sci Transl Med. 2017;9: eaal2999.","journal-title":"Sci Transl Med"},{"key":"4292_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"4292_CR37","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1213\/ANE.0b013e3181cc5727","volume":"110","author":"D Varelmann","year":"2010","unstructured":"Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010;110:868\u201370.","journal-title":"Anesth Analg"},{"key":"4292_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/abm\/kaad020","volume":"57","author":"AJ Crum","year":"2023","unstructured":"Crum AJ, Heathcote LC, Morrison Z, Yielder R, Leibowitz K, Petousis-Harris H, et al. Changing mindsets about side effects of the COVID-19 vaccination: a randomized controlled trial. Ann Behav Med. 2023;57:901\u20139.","journal-title":"Ann Behav Med"},{"key":"4292_CR39","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1073\/pnas.1720548115","volume":"115","author":"J Kirchhof","year":"2018","unstructured":"Kirchhof J, Petrakova L, Brinkhoff A, Benson S, Schmidt J, Unteroberdorster M, et al. Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci U S A. 2018;115:4223\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4292_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI83844","volume":"126","author":"M Fritz","year":"2015","unstructured":"Fritz M, Klawonn AM, Nilsson A, Singh AK, Zajdel J, Bj\u00f6rk Wilhelms D, et al. Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. J Clin Invest. 2015;126:695\u2013705.","journal-title":"J Clin Invest"},{"key":"4292_CR41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.pain.2014.01.016","volume":"155","author":"F Benedetti","year":"2014","unstructured":"Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain. 2014;155:921\u20138.","journal-title":"Pain"},{"key":"4292_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMe1104010","volume":"365","author":"D Moerman","year":"2011","unstructured":"Moerman D. Meaningful placebos \u2014 controlling the uncontrollable. N Engl J Med. 2011;365:171\u20132.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04292-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:06:18Z","timestamp":1757336778000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04292-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04292-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was conducted in accordance with the Declaration of Helsinki, approved by the local Institutional Ethics Review Board (19\u20138755-BO). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}